ストックスクリーナーアプリを入手
7.01
12.92%
-1.04
アフターアワーズ：
7.01
前日終値:
$8.05
開ける：
$7.82
24時間の取引高:
18,523
Relative Volume:
0.30
時価総額：
$50.98M
収益：
$71,000
当期純損益:
$-2.47M
株価収益率:
-0.213
EPS:
-32.9143
ネットキャッシュフロー:
$-5.24M
1週間 パフォーマンス:
-21.41%
1か月 パフォーマンス:
-30.18%
6か月 パフォーマンス:
-25.70%
1年 パフォーマンス:
-69.63%
1日の値動き範囲:
$7.01
$7.855
1週間の範囲:
$7.01
$8.70
52週間の値動き範囲:
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
7.01 | 58.55M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
86.30 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
292.33 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.60 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.00 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.20 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 開始されました | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 開始されました | Maxim Group | Buy |
Pavmed Inc (PAVM) 最新ニュース
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Q1 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed Inc (FRA:1P5) Stock Earnings Transcripts - GuruFocus
PAVmed Inc (FRA:1P5) Stock Price & 30 Year Financial Data - GuruFocus
PAVmed Inc (FRA:1P5) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
PAVmed (PAVM) 2026 proxy: ESPP share increase, director elections and auditor vote - Stock Titan
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
[ARS] PAVmed Inc. SEC Filing - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics to Hold First Quarter 2026 Business Update Con - GuruFocus
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
[EFFECT] PAVmed Inc. SEC Filing - Stock Titan
SEC Form DEFA14A filed by PAVmed Inc. - Quantisnow
PAVmed Inc. (NASDAQ: PAVM) registers 9.23M shares from Series D conversion - Stock Titan
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
PAVmed (PAVM) price target decreased by 84.60% to 41.31 - MSN
PAVmed Inc (STU:1P5) Stock PDF (Updated: 2026/04/28) - GuruFocus
Debt to equity ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Pretax income of PAVmed, Inc. – FWB:1P5 - TradingView
Free cash flow of PAVmed, Inc. – FWB:1P5 - TradingView
Return on invested capital % of PAVmed, Inc. – FWB:1P5 - TradingView
Taxes of PAVmed, Inc. – FWB:1P5 - TradingView
Debt to assets ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Total equity of PAVmed, Inc. – FWB:1P5 - TradingView
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Q2 2025 Earnings Preview - MSN
Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation Reset - Yahoo Finance
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
PAVmed (PAVM) price target increased by 2,900.00% to 321.30 - MSN
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Latest PAVM NewsPAVmed Collaborates with Canon on DisappEAR... - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics closes $18M stock offering at $1 per share By Investing.com - Investing.com India
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Backed by a $15M investor, Lucid closes $18M share sale - Stock Titan
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - Financial Times
A $15M anchor investor backs Lucid’s 18M-share stock sale - Stock Titan
PAVmed Inc. (PAVM) posts narrow Q4 2025 EPS miss, shares edge higher in muted investor trading.Community Exit Signals - Cổng thông tin điện tử tỉnh Tây Ninh
PAVmed (NASDAQ: PAVM) registers 9.23M common shares; $30M potential from warrants - Stock Titan
PAVmed IncFiles Prospectus For Potential Offer And Sale Of 9.23 Million Common Shares By Selling StockholdersSEC Filing - TradingView
Lucid Diagnostics (NASDAQ: LUCD) seeks 100M-share authorization increase - Stock Titan
PAVmed Inc. Series Z Warrant (PAVMZ) - Minichart
PAVmed (PAVM) Stock Resistance Rejection (+0.11%) 2026-04-18Sentiment Analysis - Xã Vĩnh Công
Pavmed Inc (PAVM) 財務データ
収益
当期純利益
現金流量
EPS
0.22%
0.70%
大文字化:
|
ボリューム (24 時間):